CVS Health Corp. (CVS)

65.53
0.61 0.94
NYSE : Retail Trade
Prev Close 64.92
Open 65.30
Day Low/High 64.90 / 66.32
52 Wk Low/High 60.14 / 83.88
Volume 4.75M
Avg Volume 9.20M
Exchange NYSE
Shares Outstanding 1.29B
Market Cap 84.73B
EPS 6.50
P/E Ratio 26.42
Div & Yield 2.00 (3.05%)
Index Funds vs. Mutual Funds: Which Should You Choose in 2019?

Index Funds vs. Mutual Funds: Which Should You Choose in 2019?

Index funds and mutual funds are primarily different in their investment goals, investor fees and level of management.

Video: Jim's Daily Rundown for Tuesday

Jim discusses Johnson & Johnson's quarter, recaps Schlumberger's quarter, what he's looking for when Comcast and Abbott Labs report earnings, and more!

Buy CVS Stock 'With Alacrity' If It Falls 8% From Here, Jim Cramer Says

Buy CVS Stock 'With Alacrity' If It Falls 8% From Here, Jim Cramer Says

The $65 stock will be a great deal if it falls back to $60.

CVS Reaches Pharmacy Benefits Management System Deal with Walmart

CVS Reaches Pharmacy Benefits Management System Deal with Walmart

CVS Health Corp reaches a multi-year agreement with Walmart to maintain its retail pharmacy Medicaid network and benefit management systems after warning earlier this week that the two companies had parted ways.

Weekly Roundup

U.S. markets pressed higher this week as earnings season got underway and on anticipation of a trade deal with China.

CVS Health And Walmart Announce New PBM Pharmacy Network Agreement

CVS Health And Walmart Announce New PBM Pharmacy Network Agreement

Walmart to Continue Participating in CVS Caremark Commercial and Managed Medicaid Retail Pharmacy Networks

Stocks Higher on Tuesday but CVS Lags

When we strip out the noise and the immaterial impacts surrounding CVS, what we are left with is a stock that trades at a very compelling valuation.

Video: Jim's Daily Rundown for Tuesday

Jim discusses the market and FAANG, the initial reaction to UnitedHealth's earnings, CVS, Goldman Sachs ahead of Wednesday's earnings, Citigroup, and more!

CVS Health Announces Walmart Decision To Leave CVS Caremark Commercial And Managed Medicaid Retail Pharmacy Networks

CVS Health Announces Walmart Decision To Leave CVS Caremark Commercial And Managed Medicaid Retail Pharmacy Networks

Despite market focus on reducing health care costs, Walmart requested reimbursement increases that would ultimately result in higher costs for clients and consumers

Starbucks, Square, Alibaba: 'Mad Money' Lightning Round

Starbucks, Square, Alibaba: 'Mad Money' Lightning Round

Jim Cramer weighs in on Starbucks, Square, Alibaba, ArcelorMittal, Dynavax Technologies, Aimmune Therapeutics, Clearway Energy and more.

Breaking Down Citigroup Earnings: Cramer's 'Mad Money' Recap (Monday 1/14/19)

Breaking Down Citigroup Earnings: Cramer's 'Mad Money' Recap (Monday 1/14/19)

We may be so worried about the state of the global economy that we're missing some great opportunities, Jim Cramer says.

A Checkup on CVS

Following up on our coverage of CVS, analysts at Cowen released an updated analysis this morning.

Analyst Favorites With Strong Buyback Activity: CVS Health Ranks As A Top Pick

Analyst Favorites With Strong Buyback Activity: CVS Health Ranks As A Top Pick

A study of analyst recommendations at the major brokerages shows that CVS Health Corporation is the #21 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.

CVS Health Announces $100 Million Community Commitment Following Acquisition Of Aetna

CVS Health Announces $100 Million Community Commitment Following Acquisition Of Aetna

Demonstrates newly-combined company's commitment to building healthier communities

Video: Jim's Daily Rundown for Monday

Jim recaps last week's informative trip to San Francisco and his interview with Tim Cook, and shares his thoughts on UnitedHealth Group ahead of Tuesday's earnings, Five Below's holiday sales numbers, Citigroup's earnings and much more!

Tumultuous, but Positive: Cramer's 'Mad Money' Recap (Friday 1/11/19)

Tumultuous, but Positive: Cramer's 'Mad Money' Recap (Friday 1/11/19)

This will be the craziest reporting season we've seen in ages, says Jim Cramer. He's got your game plan for next week.

Spotify, J.M. Smucker Co., Wingstop: 'Mad Money' Lightning Round

Spotify, J.M. Smucker Co., Wingstop: 'Mad Money' Lightning Round

Jim Cramer weighs in on Spotify, J.M. Smucker Co., Wingstop, Energy Transfer, Weight Watchers, Lockheed Martin, Two Harbors, Corning and more.

Weekly Roundup

The Dow, S&P 500 and Nasdaq all finished higher this week.

Adding to CVS Health

Now that CVS has pulled back, we'll pounce on this opportunity to bulk up on our position.

Keep These Themes In Mind

They continue to work in this market and we believe can drive growth longer-term.

What Is an Index Fund and What Are the Best Ways to Invest in One?

What Is an Index Fund and What Are the Best Ways to Invest in One?

Index funds offer some unique benefits - and drawbacks - compared to traditional mutual funds. Here's what you need to know.

Healthcare Updates

We have received a number of updates from analysts on the JP Morgan healthcare conference.

Video: AAP Daily Rundown for Tuesday

Zev Fima and Katherine Ross sit down to discuss Facebook, CVS, Abbott Labs and Danaher, before getting to two member questions!

Markets Open Higher on Tuesday as Trade Talks Make Progress

Plus, oil is up and portfolio name Danaher makes a positive pre-announcement.

What the Action Alerts Plus Portfolio Is Looking at This Week

What the Action Alerts Plus Portfolio Is Looking at This Week

Are you ready for the week? Action Alerts Plus's Zev Fima breaks down what the portfolio is watching.

Let's See If Friday's Sunshine Was More Than a Break in the Clouds: Market Recon

Let's See If Friday's Sunshine Was More Than a Break in the Clouds: Market Recon

It's likely that investors will be closely watching the U.S.-China trade talks to see if the skies brighten longer term.

Flexible, Patient Fed: Cramer's 'Mad Money' Recap

Flexible, Patient Fed: Cramer's 'Mad Money' Recap

Jim Cramer talks about the Fed, and outlines your game plan.

Weekly Roundup

Markets kicked off 2019 with more days of volatility.

Sifting for Stocks That Held Up in Today's Market Carnage

It was a rough day for U.S. equity markets as the Dow plunged 660 points.

TheStreet Quant Rating: C+ (Hold)